Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders

Author： Inoue Ken-ichiro   Takano Hirohisa  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.4, 2010-04, pp. : 513-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases

By Pandey Saumya   Srivastava Satish K   Ramana Kota V  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 329-339

Informa Healthcare

Access to resources Recommend Favorite

Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders

By  

Current Drug Targets, Vol. 18, Iss. 14, 2017-10 ,pp. : 1664-1675

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory Disorders and Atherosclerosis: New Therapeutic Approaches

By  

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4111-4120

Bentham Science Publishers

Access to resources Recommend Favorite

A Chaperone-Mediated Approach to Enzyme Enhancement as a Therapeutic Option for the Lysosomal Storage Disorders

By Pastores Gregory M.   Sathe Swati  

Drugs in R&D, Vol. 7, Iss. 6, 2006-01 ,pp. : 339-348

Adis International

Access to resources Recommend Favorite

Novel therapeutic strategies in acid-related disorders

By Tonini Marcello   De Giorgio Roberto   De Ponti Fabrizio  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 5, 2003-05 ,pp. : 639-649

Informa Healthcare

Access to resources Recommend Favorite